Startups

Metrion Biosciences provides specialist ion channel screening and drug discovery services.

MiAlgae produces sustainable microalgae from whisky by-products for the aquaculture and pet food sectors.

MiNA Therapeutics develops small activating RNA medicines to restore normal cell function.

Microbiotica develops microbiome-based therapeutics and precision biomarkers.

MicrofluidX provides next-generation bioreactors for cell research and manufacturing.

Microplate Dx develops a rapid diagnostic platform to identify effective antibiotic treatments.

Mission Therapeutics discovers and develops selective inhibitors for deubiquitylating enzymes.

Mogrify develops in vivo reprogramming therapies to transform patient outcomes in degenerative diseases.

Monument Therapeutics develops stratified treatments for central nervous system conditions using digital brain biomarkers.

Mosaic Therapeutics develops targeted oncology treatments using advanced computational methods and cancer genomics.